Ensysce Biosciences Inc Working Capital to Net Assets Ratio
Ensysce Biosciences Inc working capital to net assets ratio. Ensysce Biosciences Inc (ENSC) has a Working Capital to Net Assets ratio of 110.0% as of June 2026. Working capital of $-1.22 Million (current assets of $2.85 Million minus current liabilities of $4.07 Million) is measured against net assets of $-1.11 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ENSC tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Ensysce Biosciences Inc (2017–2025)
Working capital to net assets ratio of Ensysce Biosciences Inc from 2017 to 2025. This chart shows how Ensysce Biosciences Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 110.0%, reflecting working capital of $-1.22 Million against net assets of $-1.11 Million USD. See Ensysce Biosciences Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Ensysce Biosciences Inc Working Capital to Net Assets Ratio by Year (2017–2025)
Ensysce Biosciences Inc working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Ensysce Biosciences Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ENSC current and non-current assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 92.7% | $2.67 Million | $2.88 Million | $7.24 Million | $4.57 Million | ▼ -0.1 pp |
| 2024 | 92.8% | $3.14 Million | $3.38 Million | $5.34 Million | $2.21 Million | ▼ -67.5 pp |
| 2023 | 160.3% | $-1.04 Million | $-651.27K | $2.29 Million | $3.33 Million | ▲ +57.0 pp |
| 2022 | 103.4% | $-4.17 Million | $-4.03 Million | $5.30 Million | $9.46 Million | ▲ +93.3 pp |
| 2021 | 10.0% | $-819.07K | $-8.16 Million | $15.66 Million | $16.48 Million | ▼ -90.0 pp |
| 2020 | 100.1% | $-6.66 Million | $-6.66 Million | $347.88K | $7.01 Million | ▲ +100.9 pp |
| 2019 | -0.8% | $-1.57 Million | $186.17 Million | $1.20 Million | $2.77 Million | ▼ -1.6 pp |
| 2018 | 0.7% | $1.48 Million | $197.39 Million | $1.92 Million | $437.89K | ▼ -0.4 pp |
| 2017 | 1.1% | $2.15 Million | $195.27 Million | $2.31 Million | $156.24K | — |